Back to results
TerminatedN/A

EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

NCT02896816

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Spaulding Rehabilitation Hospital

Boston, Massachusetts, United States

View on ClinicalTrials.gov
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease — TrialFind